Tuesday, February 24, 2015 3:14:58 AM
As a matter of fact, the expected.
We have 4 Defendants and the weakest one of course was Shasta Technologies.
On April 16, 2014, DECN announced that Pharma Tech Solutions acquired Genstrip from Shasta Technologies.
http://finance.yahoo.com/news/decision-diagnostics-subsidiary-acquires-genstrip-131500757.html
From this day on of course, Shasta was by it’s own. With no money to pay legal expenses I would guess that they took with both hands what has been offered to them so as to close this chapter.
However from now on, J&J or Lifescan will have to deal only with DECN and this is the place where the biggest damage was done.
It is not over, rather the beginning of the poker play. Wondering what is next to be heard.
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM